Heron Therapeutics HRTX paid Farragut Partners $50K for lobbying in Q4 2023 · Health Issues, Medicare

Trade details

Type: Lobbying report
Amount: $50,000
Quarter: Q4 2023
Stock: Heron Therapeutics HRTX
Client: Heron Therapeutics
Reported: 24/01/22

Up 0.0% from last quarter

What else happened in Heron Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/01~24/01/30

Heron Therapeutics's other lobbying reports

Heron Therapeutics
LobbyingHeron Therapeutics
Lobbying
Heron Therapeutics
HRTX
$50K
$50K
Reported 07/20
for Q2
Heron Therapeutics
LobbyingHeron Therapeutics
Lobbying
Heron Therapeutics
HRTX
$50K
$50K
Reported 04/20
for Q1
Heron Therapeutics
LobbyingHeron Therapeutics
Lobbying
Heron Therapeutics
HRTX
$50K
$50K
Reported 01/20
for Q4 2025
Heron Therapeutics
LobbyingHeron Therapeutics
Lobbying
Heron Therapeutics
HRTX
$50K
$50K
Reported 25/10/20
for Q3 2025
Heron Therapeutics
LobbyingHeron Therapeutics
Lobbying
Heron Therapeutics
HRTX
$50K
$50K
Reported 25/07/21
for Q2 2025

Heron Therapeutics HRTX paid Farragut Partners $50K for lobbying in Q4 2023 · Health Issues, Medicare | Whalegun